Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior
- PMID: 15677716
- PMCID: PMC548579
- DOI: 10.1073/pnas.0409643102
Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior
Abstract
In addition to an action on metabolism, anabolic/androgenic steroids also increase sex drive and mental acuity. If abused, such steroids can cause irritability, impulsive aggression, and signs of major depression [Pearson, H. (2004) Nature 431, 500-501], but the mechanisms that produce these symptoms are unknown. The present study investigates behavioral and neurochemical alterations occurring in association with protracted (3-week) administration of testosterone propionate (TP) to socially isolated (SI) and group-housed male and female mice. Male but not female SI mice exhibit aggression that correlates with the down-regulation of brain neurosteroid biosynthesis. However, in female mice, long-term TP administration induces aggression associated with a decrease of brain allopregnanolone (Allo) content and a decrease (approximately 40%) of 5alpha-reductase type I mRNA expression. In spayed mice treated with TP, restitution experiments with progesterone and estrogen normalize brain Allo content and prevent aggression. Submicromolar doses of S-norfluoxetine (S-NFLX) that are insufficient to inhibit serotonin reuptake selectively increase brain Allo content and abolish TP-induced aggression. Our results support the view that TP-induced aggressive behavior is the result of a TP-mediated neurosteroid biosynthesis down-regulation that can be reversed by the S-NFLX-induced increase of brain Allo content.
Figures



References
-
- National Institute on Drug Abuse (2000) NIDA Research Report: Steroid Abuse and Addiction (National Clearinghouse on Alcohol and Drug Information, Rockville, MD), NIH Publication No. 00-3721 (http://165.112.78.61/ResearchReports/Steroids/Anabolicsteroids.html).
-
- Pearson, H. (2004) Nature 431, 500-501. - PubMed
-
- Lukas, S. E. (1996) Annu. Rev. Pharmacol. Toxicol. 36, 333-357. - PubMed
-
- Faigenbaum, A. D., Zaichkowshy, L. D., Gardner, D. E. & Micheli, L. J. (1998) Pediatrics 101, 1-6. - PubMed
-
- Irving, L. M., Wall, M., Neumark-Sztainer, D. & Story, M. (2002) J. Adolesc. Health 30, 243-252. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources